Maintenance therapy with immunomodulatory drugs after autologous stem cell transplantation in patients with multiple myeloma: a meta-analysis of randomized controlled trials.

PLoS One · 2013 · PMC3747129 · PMID 23977334

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

[ 23 ] showed a trend of longer OS but no significant improvement (HR 0.61, 95% CI: 0.37–1.01) when thalidomide was given as maintenance therapy following ASCT.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.